Craft

Advanced
Arrevus

Arrevus

Arrevus Summary

Company Summary

Overview
Arrevus is a biotechnology company providing therapies for orphan diseases. Arrevus develops ARV-1801, a Phase III clinical program, targeting cystic fibrosis pulmonary exacerbations, and preclinical programs to address the needs in oncology and antimicrobial resistance.
Type
Subsidiary
Status
Active
Founded
2017
Website
https://arrevus.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Carl N. Kraus

    Carl N. Kraus, President, CEO, Chairman of the Board

    • Daina Zeng

      Daina Zeng, Vice President of Research and Development

      • Denise Watts

        Denise Watts, Director, Facilities and Administration

        • Barry Garfinkle

          Barry Garfinkle, Board Member

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX